Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumors contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published in Nature.
Harvard geneticist Gary Ruvkun vividly remembers the late-night phone call with his longtime friend and now 2024 Nobel Prize in Medicine co-laureate Victor Ambros, when…
Generations of parental warnings may not be wrong: A massive study of available data finds that teens who use marijuana have significantly worse outcomes at…
Glioblastoma (GBM) is the most lethal brain tumor, with a median survival rate of merely 12-16 months after diagnosis. Despite surgical, radiation and chemotherapy treatments,…
Across the U.S., food insufficiency, defined as households not having enough food to eat, increased after pandemic-era Supplemental Nutrition Assistance Program (SNAP) emergency allotments expired,…
Our brains constantly work to make predictions about what’s going on around us, for instance to ensure that we can attend to and consider the…
A cancer vaccine that had little success in clinical trials for patients with advanced tumors could potentially have efficacy if administered earlier in the treatment…
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has revealed that common breast cancer treatments, including chemotherapy, radiation, and…
Damage to the brainstem—the brain’s ‘control center’—is behind long-lasting physical and psychiatric effects of severe COVID-19 infection, a study suggests.
In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely…
Multiple myeloma is a type of blood cancer that appears mainly after the age of 60. Its incidence, therefore, increases with the aging of the…
